View Clinical Trial (Medical Research Study)

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease - NCT00791557-44106(Clinical Trial 253260)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Cleveland
State:  
OH
Zip Code: 44106
Conditions: Pyoderma Gangrenosum - Crohn's Disease - Ulcerative Colitis - Inflammatory Bowel Disease
Purpose: Subjects must be 18- 75 years old and have a history of both inflammatory bowels disease (Crohn's or ulcerative colitis) and pyoderma gangrenosum. This is a 6 month open label study of an intravenous (IV) medication. Visits occur every 2 weeks initially, then every 1-2 months later in the study.
Study summary:
Criteria: Inclusion Criteria: - Must Be ages 18-75 - Must have both inflammatory bowel disease and moderate to severe pyoderma gangrenosum - Must never have received Infliximab for the treatment of pyoderma gangrenosum Exclusion Criteria: - Have had any previous treatment with monoclonal antibodies other than infliximab used to treat IBD or antibody fragments. - Have a history of serious infections
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: June 22, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.